Hong Kong Water Utilities Stock News

Yangtze Optical Fibre And Cable Limited (SEHK:6869) experienced a remarkable price move of 249% over the last quarter, following the announcement of its half-year earnings results. Despite showing growth in sales and revenue, the company reported a decline in net income and earnings per share, which could pose concerns for stakeholders. This performance may have influenced investor sentiment contributing to its stock fluctuation. The company's broader market context saw overall positive...

Semiconductor Manufacturing International (SEHK:981) is preparing to announce its unaudited interim results for the first half of 2025, with the board meeting and earnings release scheduled for August 28. The company's recent 58% price surge over the last quarter could be influenced by its recent Q2 earnings report, indicating sales of $2,209 million and net income of $132 million, alongside a positive revenue growth guidance. This reflects positively amid a broader market rally, supported by...

China Everbright (SEHK:165) experienced a significant price movement over the last quarter, increasing by 69%. This move aligns with the broader market trends where major indices, such as the Dow Jones, have reached record highs amid positive economic indicators and anticipated Federal Reserve interest rate cuts. Within this context, the company's strong earnings report, contrasting last year's losses, and an announced interim dividend would have added weight to Everbright's positive...

NetEase (SEHK:9999) recently announced a lower dividend, alongside its notable Q2 financial performance showing increased sales and net income. With a new independent director appointed to its board and ongoing share repurchase activity, the company's strategic maneuverings continue to shape investor perception. Over the last month, NetEase's share price rose by 12.52%, an increase that aligns with broader market trends, as U.S. stock indices also experienced gains thanks to cooling inflation...

Unisound AI Technology (SEHK:9678) caught the attention of investors this week with a move in its share price, prompting debate about what might be driving momentum, or if it signals fresh risks or opportunity for the company. While there hasn’t been a clear event or announcement to point to, these kinds of movements often act as a spark for investors to take a closer look at what’s happening under the hood, especially when it comes to future prospects versus the current price tag. Stepping...

As global markets navigate the complexities of economic shifts, including a weakening U.S. labor market and fluctuating interest rates, investors are increasingly exploring diverse opportunities across different regions. Penny stocks, often associated with smaller or newer companies, continue to captivate attention due to their affordability and potential for growth when supported by robust financials. This article highlights several noteworthy Asian penny stocks that exemplify these...

There's no doubt that investing in the stock market is a truly brilliant way to build wealth. But if you choose that...

China State Construction International Holdings ( HKG:3311 ) First Half 2025 Results Key Financial Results Revenue...

Dream International Limited ( HKG:1126 ) will pay a dividend of HK$0.25 on the 13th of October. This makes the dividend...

Ming Fai International Holdings Limited ( HKG:3828 ) has announced that it will pay a dividend of HK$0.03 per share on...

CK Asset Holdings Limited ( HKG:1113 ) stock is about to trade ex-dividend in four days. The ex-dividend date is...

Lotus Horizon Holdings Limited's ( HKG:6063 ) price-to-sales (or "P/S") ratio of 1.4x may not look like an appealing...

China Unicom (Hong Kong) Limited's ( HKG:762 ) robust earnings report didn't manage to move the market for its stock...

ZhongAn Online P & C Insurance Co., Ltd.'s ( HKG:6060 ) price-to-earnings (or "P/E") ratio of 23.3x might make it look...

As global markets navigate a period of economic uncertainty, with mixed signals from major economies such as the U.S. and China, investors are increasingly looking toward Asia for opportunities in growth stocks. In this context, companies with high insider ownership can offer an added layer of confidence, as significant insider stakes often align management's interests with those of shareholders and may indicate potential resilience amid fluctuating market conditions.

Amidst a backdrop of global economic shifts, Asian markets have been navigating through a mix of optimism and caution, with China's stock markets recently experiencing volatility due to domestic liquidity surges and broader economic concerns. In this dynamic environment, identifying high-growth tech stocks requires a keen eye on innovation potential and resilience in the face of fluctuating market conditions.

Viewing insider transactions for HKT Trust and HKT Limited's ( HKG:6823 ) over the last year, we see that insiders were...

As the Asian markets navigate a complex global landscape marked by economic uncertainties and shifting interest rate expectations, investors are increasingly seeking opportunities that offer both stability and growth potential. Penny stocks, despite their somewhat outdated moniker, remain an intriguing investment area for those looking to explore smaller or newer companies with promising financial health. In this article, we spotlight several penny stocks in Asia that stand out for their...

XtalPi Holdings (SEHK:2228) recently announced a significant milestone as its next-generation PRMT5 inhibitor, PEP08, received regulatory approvals to begin Phase 1 clinical trials for solid tumors. This development underscores the company's advanced capabilities in drug discovery, likely contributing to the impressive 65% rise in its stock price over the last quarter. Alongside broader tech market gains, highlighted by the S&P 500 and Nasdaq reaching new highs, XtalPi's earnings reports...

Cirrus Aircraft (SEHK:2507) reported a strong earnings performance for the half year ended June 30, 2025, with sales rising to USD 594 million from USD 475 million, and net income increasing to USD 65 million, providing a potential catalyst for its share price increase of 42% over the last quarter. These financial results likely underscored confidence in the company amidst a generally robust market environment, where the S&P 500 and Nasdaq hit all-time highs. The company's dividend...

Pop Mart International Group (SEHK:9992) saw its shares rise by 3.15% over the last quarter, a period marked by key developments like its inclusion in both the Hang Seng Index and the Hang Seng China Enterprises Index on September 8, 2025. This addition underscores the company's growing prominence following impressive financial results reported on August 19, 2025, which showed significant year-over-year gains in sales and net income. During this time, major indices like the S&P 500 and Nasdaq...

Akeso (SEHK:9926) recently captured attention by presenting promising data on its cadonilimab therapy at the World Conference on Lung Cancer, highlighting its potential as a breakthrough treatment for immunotherapy-resistant non-small cell lung cancer. Over the last quarter, the company's share price surged 40%, potentially influenced by these significant clinical developments and the awarding of Breakthrough Therapy Designation. The broader market trend, which saw indices like the S&P 500...

Ascletis Pharma (SEHK:1672) recently announced noteworthy advancements related to its investigational drug ASC30, showcasing a promising 75-day half-life in a clinical study, which propelled excitement around potential once-quarterly administration for obesity management. As a result, the company's share price increased by nearly 48% over the last quarter. This rise occurred against a backdrop of broader market gains, with indexes like the Nasdaq and S&P 500 reaching all-time highs,...

Innovent Biologics (SEHK:1801) has recently been part of a significant client announcement, with a new partnership with Fangzhou Inc. aimed at integrating digital health services into innovative therapies for metabolic diseases. This event coincided with the company's share price rising 23% over the last quarter. Aside from this strategic move, the company has also witnessed FDA approval for key investigational drugs such as IBI363, adding weight to its impressive price performance. However,...